Tudor Investment Corp
ASND icon

Tudor Investment Corp’s Ascendis Pharma A/S ASND Stock Holding History

Tudor Investment Corp’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,299
Closed -$3.32M – 3225
2025
Q1 		$3.32M Buy
+21,299
New +$3.04M 0.01% 1013
2024
Q4 		– Sell
-25,891
Closed -$3.87M – 2994
2024
Q3 		$3.87M Sell
25,891
-7,484
-22% -$1.01M 0.01% 841
2024
Q2 		$4.55M Buy
+33,375
New +$4.54M 0.02% 693
2023
Q4 		– Sell
-3,413
Closed -$320K – 2353
2023
Q3 		$320K Buy
+3,413
New +$319K ﹤0.01% 1902
2023
Q1 		– Sell
-27,476
Closed -$3.36M – 2386
2022
Q4 		$3.36M Sell
27,476
-4,456
-14% -$517K 0.07% 378
2022
Q3 		$3.3M Buy
31,932
+11,118
+53% +$1.05M 0.07% 348
2022
Q2 		$1.94M Buy
+20,814
New +$1.96M 0.05% 531
2021
Q3 		– Sell
-8,509
Closed -$1.12M – 2435
2021
Q2 		$1.12M Sell
8,509
-10,353
-55% -$1.38M 0.02% 811
2021
Q1 		$2.43M Buy
18,862
+5,990
+47% +$910K 0.05% 436
2020
Q4 		$2.15M Buy
12,872
+8,172
+174% +$1.35M 0.06% 398
2020
Q3 		$725K Buy
4,700
+1,575
+50% +$226K 0.03% 680
2020
Q2 		$462K Buy
+3,125
New +$429K 0.02% 753
2018
Q2 		– Sell
-11,705
Closed -$766K – 1037
2018
Q1 		$766K Buy
11,705
+4,195
+56% +$236K 0.02% 413
2017
Q4 		$301K Buy
7,510
+1,592
+27% +$57.9K 0.01% 799
2017
Q3 		$215K Buy
+5,918
New +$170K 0.01% 933

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tudor Investment Corp's ASND Position: Q2 2025 in Review

Tudor Investment Corp sold out of Ascendis Pharma A/S (ASND) in Q2 2025, closing a stake of 21,299 shares — an estimated $3.32M sold.

Tudor Investment Corp first reported a position in ASND in Q3 2017 and held it in 15 quarters. The position peaked at $4.55M in Q2 2024. 247 funds tracked by Wall St. Rank hold ASND as of Q2 2025.

  • Tudor Investment Corp reported no remaining Ascendis Pharma A/S position as of Q2 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 21,299 Ascendis Pharma A/S shares in Q2 2025, an estimated $3.32M.
  • Tudor Investment Corp first reported a position in Ascendis Pharma A/S in Q3 2017 and held it in 15 quarters.
  • Tudor Investment Corp's Ascendis Pharma A/S position peaked at $4.55M in Q2 2024.
  • 247 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.